(Q34490418)

2 August 2017

1 reference

title

Management of Parkinson's disease. Strategies, pitfalls, and future directions (English)

1 reference

2 August 2017

Hermanowicz N

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

2 August 2017

published in

Postgraduate Medicine

1 reference

2 August 2017

volume

110

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

15-8, 21-3, 28

1 reference

Parkinson's disease. First of two parts

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

Association of coffee and caffeine intake with the risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

Smoking and Parkinson's disease: a dose-response relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

Parkinson disease in twins: an etiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

A community-based study of sleep disorders in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

Risk factors for depression in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

Acute delirium after withdrawal of amantadine in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

Familial Aggregation of Parkinson's Disease in Iceland

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2001.12.1060

21 January 2018

Identifiers

DOI

10.3810/PGM.2001.12.1060

1 reference

2 August 2017

1 reference